Reviews Rifampin, Isoniazid and Pyrazinamide


No reviews yet.

Rifater Drug Description
RIFATER®
(rifampin, isoniazid and pyrazinamide) Tablets

WARNING
Severe and sometimes fatal hepatitis associated with isoniazid therapy may occur and may develop even after many months of treatment. The risk of developing hepatitis is age related. Approximate case rates by age are: 0 per 1,000 for persons under 20 years of age, 3 per 1,000 for persons in the 20 to 34 year age group, 12 per 1,000 for persons in the 35 to 49 year age group, 23 per 1,000 for persons in the 50 to 64 year age group, and 8 per 1,000 for persons over 65 years of age. The risk of hepatitis is increased with daily consumption of alcohol. Precise data to provide a fatality rate for isoniazid-related hepatitis is not available; however, in a U.S. Public Health Service Surveillance Study of 13,838 persons taking isoniazid, there were 8 deaths among 174 cases of hepatitis.
Therefore, patients given isoniazid should be carefully monitored and interviewed at monthly intervals. Serum transaminase concentration becomes elevated in about 10% to 20% of patients, usually during the first few months of therapy, but it can occur at any time. Usually enzyme levels return to normal despite continuance of drug, but in some cases progressive liver dysfunction occurs. Patients should be instructed to report immediately any of the prodromal symptoms of hepatitis, such as fatigue, weakness, malaise, anorexia, nausea, or vomiting. If these symptoms appear or if signs suggestive of hepatic damage are detected, isoniazid should be discontinued promptly since continued use of the drug in these cases has been reported to cause a more severe form of liver damage.
Patients with tuberculosis should be given appropriate treatment with alternative drugs. If isoniazid must be reinstituted, it should be reinstituted only after symptoms and laboratory abnormalities have cleared. The drug should be restarted in very small and gradually increasing doses and should be withdrawn immediately if there is any indication of recurrent liver involvement. Treatment should be deferred in persons with acute hepatic diseases.

DRUG DESCRIPTION



What are the possible side effects of isoniazid, pyrazinamide, and rifampin (Rifater)?

If you experience any of the following serious side effects, stop taking isoniazid, pyrazinamide, and rifampin and seek emergency medical attention or contact your doctor immediately:

an allergic reaction (difficulty breathing; closing of your throat; swelling of your lips, tongue, or face; or hives);
excessive tiredness or weakness;
nausea, vomiting, diarrhea, or loss of appetite;
yellow skin or eyes;
unusual bruising or...
Read All Potential Side Effects for Rifater »




RIFATER (rifampin/isoniazid/pyrazinamide) tablets are combination tablets containing 120 mg rifampin, 50 mg isoniazid, and 300 mg pyrazinamide for use in antibacterial therapy. The tablets also contain as inactive ingredients: povidone, carboxymethylcellulose sodium, calcium stearate, sodium lauryl sulfate, sucrose, talc, acacia, titanium dioxide, kaolin, magnesium carbonate, colloidal silicon dioxide, dried aluminum hydroxide gel, ferric oxide, black iron oxide, carnauba wax, white beeswax, colophony, hard paraffin, lecithin, shellac, and propylene glycol. The RIFATER triple therapy combination was developed for dosing convenience.
Rifampin is a semisynthetic antibiotic derivative of rifamycin SV. Rifampin
is a red-brown crystalline powder very slightly soluble in water at neutral
pH, freely soluble in chloroform, soluble in ethyl acetate and methanol. Its
molecular weight is 822.95 and its chemical formula is C43H58N4O12.
The chemical name for rifampin is either:
3-[[(4-methyl-1-piperazinyl) imino]-methyl]-rifamycin;
or
5,6,9,17,19,21-hexahydroxy-23methoxy-2,4,12,16,18,20,22
heptamethyl-8-[N-(4-methyl-1-piperazinyl) formimidoyl]-2,7-(epoxypentadeca
[1,11,13]trienimino)naphtho[2,1-b]furan-1, 11(2H)-dione 21-acetate.
ITS STRUCTURAL FORMULA IS:








Isoniazid is the hydroxide of isonicotinic acid. It is a colorless or white
crystalline powder or white crystals. It is odorless and slowly affected by
exposure to air and light. It is freely soluble in water, sparingly soluble
in alcohol and slightly soluble in chloroform and in ether. Its molecular weight
is 137.14 and its chemical formula is C6H7N3O.
The chemical name for isoniazid is 4-pyridinecarboxylic acid, hydrazide and
its structural formula is:








Pyrazinamide, the pyrazine analogue of nicotinamide, is a white, crystalline
powder, stable at room temperature, and sparingly soluble in water. The chemical
name for pyrazinamide is pyrazinecarboxamide and its molecular weight is 123.11.
Its chemical formula is C5H5N3O and its structural
formula is:







Last reviewed on RxList: 2/13/2009




Rifater Drug Description
RIFATER®
(rifampin, isoniazid and pyrazinamide) Tablets

WARNING
Severe and sometimes fatal hepatitis associated with isoniazid therapy may occur and may develop even after many months of treatment. The risk of developing hepatitis is age related. Approximate case rates by age are: 0 per 1,000 for persons under 20 years of age, 3 per 1,000 for persons in the 20 to 34 year age group, 12 per 1,000 for persons in the 35 to 49 year age group, 23 per 1,000 for persons in the 50 to 64 year age group, and 8 per 1,000 for persons over 65 years of age. The risk of hepatitis is increased with daily consumption of alcohol. Precise data to provide a fatality rate for isoniazid-related hepatitis is not available; however, in a U.S. Public Health Service Surveillance Study of 13,838 persons taking isoniazid, there were 8 deaths among 174 cases of hepatitis.
Therefore, patients given isoniazid should be carefully monitored and interviewed at monthly intervals. Serum transaminase concentration becomes elevated in about 10% to 20% of patients, usually during the first few months of therapy, but it can occur at any time. Usually enzyme levels return to normal despite continuance of drug, but in some cases progressive liver dysfunction occurs. Patients should be instructed to report immediately any of the prodromal symptoms of hepatitis, such as fatigue, weakness, malaise, anorexia, nausea, or vomiting. If these symptoms appear or if signs suggestive of hepatic damage are detected, isoniazid should be discontinued promptly since continued use of the drug in these cases has been reported to cause a more severe form of liver damage.
Patients with tuberculosis should be given appropriate treatment with alternative drugs. If isoniazid must be reinstituted, it should be reinstituted only after symptoms and laboratory abnormalities have cleared. The drug should be restarted in very small and gradually increasing doses and should be withdrawn immediately if there is any indication of recurrent liver involvement. Treatment should be deferred in persons with acute hepatic diseases.

DRUG DESCRIPTION



What are the possible side effects of isoniazid, pyrazinamide, and rifampin (Rifater)?

If you experience any of the following serious side effects, stop taking isoniazid, pyrazinamide, and rifampin and seek emergency medical attention or contact your doctor immediately:

an allergic reaction (difficulty breathing; closing of your throat; swelling of your lips, tongue, or face; or hives);
excessive tiredness or weakness;
nausea, vomiting, diarrhea, or loss of appetite;
yellow skin or eyes;
unusual bruising or...
Read All Potential Side Effects for Rifater »




RIFATER (rifampin/isoniazid/pyrazinamide) tablets are combination tablets containing 120 mg rifampin, 50 mg isoniazid, and 300 mg pyrazinamide for use in antibacterial therapy. The tablets also contain as inactive ingredients: povidone, carboxymethylcellulose sodium, calcium stearate, sodium lauryl sulfate, sucrose, talc, acacia, titanium dioxide, kaolin, magnesium carbonate, colloidal silicon dioxide, dried aluminum hydroxide gel, ferric oxide, black iron oxide, carnauba wax, white beeswax, colophony, hard paraffin, lecithin, shellac, and propylene glycol. The RIFATER triple therapy combination was developed for dosing convenience.
Rifampin is a semisynthetic antibiotic derivative of rifamycin SV. Rifampin
is a red-brown crystalline powder very slightly soluble in water at neutral
pH, freely soluble in chloroform, soluble in ethyl acetate and methanol. Its
molecular weight is 822.95 and its chemical formula is C43H58N4O12.
The chemical name for rifampin is either:
3-[[(4-methyl-1-piperazinyl) imino]-methyl]-rifamycin;
or
5,6,9,17,19,21-hexahydroxy-23methoxy-2,4,12,16,18,20,22
heptamethyl-8-[N-(4-methyl-1-piperazinyl) formimidoyl]-2,7-(epoxypentadeca
[1,11,13]trienimino)naphtho[2,1-b]furan-1, 11(2H)-dione 21-acetate.
ITS STRUCTURAL FORMULA IS:








Isoniazid is the hydroxide of isonicotinic acid. It is a colorless or white
crystalline powder or white crystals. It is odorless and slowly affected by
exposure to air and light. It is freely soluble in water, sparingly soluble
in alcohol and slightly soluble in chloroform and in ether. Its molecular weight
is 137.14 and its chemical formula is C6H7N3O.
The chemical name for isoniazid is 4-pyridinecarboxylic acid, hydrazide and
its structural formula is:








Pyrazinamide, the pyrazine analogue of nicotinamide, is a white, crystalline
powder, stable at room temperature, and sparingly soluble in water. The chemical
name for pyrazinamide is pyrazinecarboxamide and its molecular weight is 123.11.
Its chemical formula is C5H5N3O and its structural
formula is:







Last reviewed on RxList: 2/13/2009




Rifater Drug Description
RIFATER®
(rifampin, isoniazid and pyrazinamide) Tablets

WARNING
Severe and sometimes fatal hepatitis associated with isoniazid therapy may occur and may develop even after many months of treatment. The risk of developing hepatitis is age related. Approximate case rates by age are: 0 per 1,000 for persons under 20 years of age, 3 per 1,000 for persons in the 20 to 34 year age group, 12 per 1,000 for persons in the 35 to 49 year age group, 23 per 1,000 for persons in the 50 to 64 year age group, and 8 per 1,000 for persons over 65 years of age. The risk of hepatitis is increased with daily consumption of alcohol. Precise data to provide a fatality rate for isoniazid-related hepatitis is not available; however, in a U.S. Public Health Service Surveillance Study of 13,838 persons taking isoniazid, there were 8 deaths among 174 cases of hepatitis.
Therefore, patients given isoniazid should be carefully monitored and interviewed at monthly intervals. Serum transaminase concentration becomes elevated in about 10% to 20% of patients, usually during the first few months of therapy, but it can occur at any time. Usually enzyme levels return to normal despite continuance of drug, but in some cases progressive liver dysfunction occurs. Patients should be instructed to report immediately any of the prodromal symptoms of hepatitis, such as fatigue, weakness, malaise, anorexia, nausea, or vomiting. If these symptoms appear or if signs suggestive of hepatic damage are detected, isoniazid should be discontinued promptly since continued use of the drug in these cases has been reported to cause a more severe form of liver damage.
Patients with tuberculosis should be given appropriate treatment with alternative drugs. If isoniazid must be reinstituted, it should be reinstituted only after symptoms and laboratory abnormalities have cleared. The drug should be restarted in very small and gradually increasing doses and should be withdrawn immediately if there is any indication of recurrent liver involvement. Treatment should be deferred in persons with acute hepatic diseases.

DRUG DESCRIPTION



What are the possible side effects of isoniazid, pyrazinamide, and rifampin (Rifater)?

If you experience any of the following serious side effects, stop taking isoniazid, pyrazinamide, and rifampin and seek emergency medical attention or contact your doctor immediately:

an allergic reaction (difficulty breathing; closing of your throat; swelling of your lips, tongue, or face; or hives);
excessive tiredness or weakness;
nausea, vomiting, diarrhea, or loss of appetite;
yellow skin or eyes;
unusual bruising or...
Read All Potential Side Effects for Rifater »




RIFATER (rifampin/isoniazid/pyrazinamide) tablets are combination tablets containing 120 mg rifampin, 50 mg isoniazid, and 300 mg pyrazinamide for use in antibacterial therapy. The tablets also contain as inactive ingredients: povidone, carboxymethylcellulose sodium, calcium stearate, sodium lauryl sulfate, sucrose, talc, acacia, titanium dioxide, kaolin, magnesium carbonate, colloidal silicon dioxide, dried aluminum hydroxide gel, ferric oxide, black iron oxide, carnauba wax, white beeswax, colophony, hard paraffin, lecithin, shellac, and propylene glycol. The RIFATER triple therapy combination was developed for dosing convenience.
Rifampin is a semisynthetic antibiotic derivative of rifamycin SV. Rifampin
is a red-brown crystalline powder very slightly soluble in water at neutral
pH, freely soluble in chloroform, soluble in ethyl acetate and methanol. Its
molecular weight is 822.95 and its chemical formula is C43H58N4O12.
The chemical name for rifampin is either:
3-[[(4-methyl-1-piperazinyl) imino]-methyl]-rifamycin;
or
5,6,9,17,19,21-hexahydroxy-23methoxy-2,4,12,16,18,20,22
heptamethyl-8-[N-(4-methyl-1-piperazinyl) formimidoyl]-2,7-(epoxypentadeca
[1,11,13]trienimino)naphtho[2,1-b]furan-1, 11(2H)-dione 21-acetate.
ITS STRUCTURAL FORMULA IS:








Isoniazid is the hydroxide of isonicotinic acid. It is a colorless or white
crystalline powder or white crystals. It is odorless and slowly affected by
exposure to air and light. It is freely soluble in water, sparingly soluble
in alcohol and slightly soluble in chloroform and in ether. Its molecular weight
is 137.14 and its chemical formula is C6H7N3O.
The chemical name for isoniazid is 4-pyridinecarboxylic acid, hydrazide and
its structural formula is:








Pyrazinamide, the pyrazine analogue of nicotinamide, is a white, crystalline
powder, stable at room temperature, and sparingly soluble in water. The chemical
name for pyrazinamide is pyrazinecarboxamide and its molecular weight is 123.11.
Its chemical formula is C5H5N3O and its structural
formula is:







Last reviewed on RxList: 2/13/2009




Rifater Drug Description
RIFATER®
(rifampin, isoniazid and pyrazinamide) Tablets

WARNING
Severe and sometimes fatal hepatitis associated with isoniazid therapy may occur and may develop even after many months of treatment. The risk of developing hepatitis is age related. Approximate case rates by age are: 0 per 1,000 for persons under 20 years of age, 3 per 1,000 for persons in the 20 to 34 year age group, 12 per 1,000 for persons in the 35 to 49 year age group, 23 per 1,000 for persons in the 50 to 64 year age group, and 8 per 1,000 for persons over 65 years of age. The risk of hepatitis is increased with daily consumption of alcohol. Precise data to provide a fatality rate for isoniazid-related hepatitis is not available; however, in a U.S. Public Health Service Surveillance Study of 13,838 persons taking isoniazid, there were 8 deaths among 174 cases of hepatitis.
Therefore, patients given isoniazid should be carefully monitored and interviewed at monthly intervals. Serum transaminase concentration becomes elevated in about 10% to 20% of patients, usually during the first few months of therapy, but it can occur at any time. Usually enzyme levels return to normal despite continuance of drug, but in some cases progressive liver dysfunction occurs. Patients should be instructed to report immediately any of the prodromal symptoms of hepatitis, such as fatigue, weakness, malaise, anorexia, nausea, or vomiting. If these symptoms appear or if signs suggestive of hepatic damage are detected, isoniazid should be discontinued promptly since continued use of the drug in these cases has been reported to cause a more severe form of liver damage.
Patients with tuberculosis should be given appropriate treatment with alternative drugs. If isoniazid must be reinstituted, it should be reinstituted only after symptoms and laboratory abnormalities have cleared. The drug should be restarted in very small and gradually increasing doses and should be withdrawn immediately if there is any indication of recurrent liver involvement. Treatment should be deferred in persons with acute hepatic diseases.

DRUG DESCRIPTION



What are the possible side effects of isoniazid, pyrazinamide, and rifampin (Rifater)?

If you experience any of the following serious side effects, stop taking isoniazid, pyrazinamide, and rifampin and seek emergency medical attention or contact your doctor immediately:

an allergic reaction (difficulty breathing; closing of your throat; swelling of your lips, tongue, or face; or hives);
excessive tiredness or weakness;
nausea, vomiting, diarrhea, or loss of appetite;
yellow skin or eyes;
unusual bruising or...
Read All Potential Side Effects for Rifater »




RIFATER (rifampin/isoniazid/pyrazinamide) tablets are combination tablets containing 120 mg rifampin, 50 mg isoniazid, and 300 mg pyrazinamide for use in antibacterial therapy. The tablets also contain as inactive ingredients: povidone, carboxymethylcellulose sodium, calcium stearate, sodium lauryl sulfate, sucrose, talc, acacia, titanium dioxide, kaolin, magnesium carbonate, colloidal silicon dioxide, dried aluminum hydroxide gel, ferric oxide, black iron oxide, carnauba wax, white beeswax, colophony, hard paraffin, lecithin, shellac, and propylene glycol. The RIFATER triple therapy combination was developed for dosing convenience.
Rifampin is a semisynthetic antibiotic derivative of rifamycin SV. Rifampin
is a red-brown crystalline powder very slightly soluble in water at neutral
pH, freely soluble in chloroform, soluble in ethyl acetate and methanol. Its
molecular weight is 822.95 and its chemical formula is C43H58N4O12.
The chemical name for rifampin is either:
3-[[(4-methyl-1-piperazinyl) imino]-methyl]-rifamycin;
or
5,6,9,17,19,21-hexahydroxy-23methoxy-2,4,12,16,18,20,22
heptamethyl-8-[N-(4-methyl-1-piperazinyl) formimidoyl]-2,7-(epoxypentadeca
[1,11,13]trienimino)naphtho[2,1-b]furan-1, 11(2H)-dione 21-acetate.
ITS STRUCTURAL FORMULA IS:








Isoniazid is the hydroxide of isonicotinic acid. It is a colorless or white
crystalline powder or white crystals. It is odorless and slowly affected by
exposure to air and light. It is freely soluble in water, sparingly soluble
in alcohol and slightly soluble in chloroform and in ether. Its molecular weight
is 137.14 and its chemical formula is C6H7N3O.
The chemical name for isoniazid is 4-pyridinecarboxylic acid, hydrazide and
its structural formula is:








Pyrazinamide, the pyrazine analogue of nicotinamide, is a white, crystalline
powder, stable at room temperature, and sparingly soluble in water. The chemical
name for pyrazinamide is pyrazinecarboxamide and its molecular weight is 123.11.
Its chemical formula is C5H5N3O and its structural
formula is:







Last reviewed on RxList: 2/13/2009




Rifater Drug Description
RIFATER®
(rifampin, isoniazid and pyrazinamide) Tablets

WARNING
Severe and sometimes fatal hepatitis associated with isoniazid therapy may occur and may develop even after many months of treatment. The risk of developing hepatitis is age related. Approximate case rates by age are: 0 per 1,000 for persons under 20 years of age, 3 per 1,000 for persons in the 20 to 34 year age group, 12 per 1,000 for persons in the 35 to 49 year age group, 23 per 1,000 for persons in the 50 to 64 year age group, and 8 per 1,000 for persons over 65 years of age. The risk of hepatitis is increased with daily consumption of alcohol. Precise data to provide a fatality rate for isoniazid-related hepatitis is not available; however, in a U.S. Public Health Service Surveillance Study of 13,838 persons taking isoniazid, there were 8 deaths among 174 cases of hepatitis.
Therefore, patients given isoniazid should be carefully monitored and interviewed at monthly intervals. Serum transaminase concentration becomes elevated in about 10% to 20% of patients, usually during the first few months of therapy, but it can occur at any time. Usually enzyme levels return to normal despite continuance of drug, but in some cases progressive liver dysfunction occurs. Patients should be instructed to report immediately any of the prodromal symptoms of hepatitis, such as fatigue, weakness, malaise, anorexia, nausea, or vomiting. If these symptoms appear or if signs suggestive of hepatic damage are detected, isoniazid should be discontinued promptly since continued use of the drug in these cases has been reported to cause a more severe form of liver damage.
Patients with tuberculosis should be given appropriate treatment with alternative drugs. If isoniazid must be reinstituted, it should be reinstituted only after symptoms and laboratory abnormalities have cleared. The drug should be restarted in very small and gradually increasing doses and should be withdrawn immediately if there is any indication of recurrent liver involvement. Treatment should be deferred in persons with acute hepatic diseases.

DRUG DESCRIPTION



What are the possible side effects of isoniazid, pyrazinamide, and rifampin (Rifater)?

If you experience any of the following serious side effects, stop taking isoniazid, pyrazinamide, and rifampin and seek emergency medical attention or contact your doctor immediately:

an allergic reaction (difficulty breathing; closing of your throat; swelling of your lips, tongue, or face; or hives);
excessive tiredness or weakness;
nausea, vomiting, diarrhea, or loss of appetite;
yellow skin or eyes;
unusual bruising or...
Read All Potential Side Effects for Rifater »




RIFATER (rifampin/isoniazid/pyrazinamide) tablets are combination tablets containing 120 mg rifampin, 50 mg isoniazid, and 300 mg pyrazinamide for use in antibacterial therapy. The tablets also contain as inactive ingredients: povidone, carboxymethylcellulose sodium, calcium stearate, sodium lauryl sulfate, sucrose, talc, acacia, titanium dioxide, kaolin, magnesium carbonate, colloidal silicon dioxide, dried aluminum hydroxide gel, ferric oxide, black iron oxide, carnauba wax, white beeswax, colophony, hard paraffin, lecithin, shellac, and propylene glycol. The RIFATER triple therapy combination was developed for dosing convenience.
Rifampin is a semisynthetic antibiotic derivative of rifamycin SV. Rifampin
is a red-brown crystalline powder very slightly soluble in water at neutral
pH, freely soluble in chloroform, soluble in ethyl acetate and methanol. Its
molecular weight is 822.95 and its chemical formula is C43H58N4O12.
The chemical name for rifampin is either:
3-[[(4-methyl-1-piperazinyl) imino]-methyl]-rifamycin;
or
5,6,9,17,19,21-hexahydroxy-23methoxy-2,4,12,16,18,20,22
heptamethyl-8-[N-(4-methyl-1-piperazinyl) formimidoyl]-2,7-(epoxypentadeca
[1,11,13]trienimino)naphtho[2,1-b]furan-1, 11(2H)-dione 21-acetate.
ITS STRUCTURAL FORMULA IS:








Isoniazid is the hydroxide of isonicotinic acid. It is a colorless or white
crystalline powder or white crystals. It is odorless and slowly affected by
exposure to air and light. It is freely soluble in water, sparingly soluble
in alcohol and slightly soluble in chloroform and in ether. Its molecular weight
is 137.14 and its chemical formula is C6H7N3O.
The chemical name for isoniazid is 4-pyridinecarboxylic acid, hydrazide and
its structural formula is:








Pyrazinamide, the pyrazine analogue of nicotinamide, is a white, crystalline
powder, stable at room temperature, and sparingly soluble in water. The chemical
name for pyrazinamide is pyrazinecarboxamide and its molecular weight is 123.11.
Its chemical formula is C5H5N3O and its structural
formula is:







Last reviewed on RxList: 2/13/2009





Other reviews about Rifampin, Isoniazid and Pyrazinamide on wordpress

Extensively Drug-Resistant (EDR) Tuberculosis (TB) Patient
  by J
It's big news here in North America and worldwide. Here are a few links: 1. Search on for those exposed to TB-infected man on flights 2. Drug-Resistant TB Patient in […]


References: Silicosis
  by nat
Table of Contents RED: Pellagra's about as bad among the women as silicosis is with the men. The Basics Silicosis (also known as Grinder's disease and Potter's rot) is a form […]


the classic crime
  by ternarycomplex
Well, I guess every day can't be a good day.  For whatever reason (and I could probably tell you if you want to know), I've started to avoid […]


TUBERCULOSIS
  by ongz5050
Tuberculosis is a common and often deadly infectious disease caused by mycobacteria, mainly mycobacterium tuberculosis. Tuberculosis usually attacks the lungs (as pulmonaryTB) but can also affect the central nervous […]


Drug-resistant tuberculosis
  by shubhamprakashgoelfitness
Drug-resistant tuberculosis by: Shubham Prakash Goel Drug-resistant tuberculosis Guidelines for the programmatic management of drug-resistant tuberculosis.  That is not happening in much of the world today, leading to increasing problems of drug-resistant […]


REFERENCE TUBERCULOSIS IN CHILDREN
  by childrenclinic
Girgis NI, Fariz Z, Kilpatrick ME, et al. Dexamethasone adjunctive treatment for tuberculous meningitis. Pediatr Infect Dis J 1991;10:179-182 Swanson DS, Starke JR. Drug-resistant tuberculosis in pediatrics. Pediatr Clin […]


HIV IN CHILDREN : FOLLOW UP
  by Indonesian Children
Follow-Up Further Outpatient Care: Children should be monitored every 1-3 months, depending on their clinical status. Anthropometric parameters should be measured and dietary habits reviewed at each clinical visit to monitor […]


Tuberculosis
  by tuberculosissymp2
  Symptoms of TB Tuberculosis infection will usually start  in the upper portion or lobe of the lungs. It is possible for the immune system to prevent the multiplication of […]


Pills, pills, and more pills
  by mpsub11
So, my first week has wrapped up and I have to say I learned quite a lot. My first day was pretty interesting. After getting lost on the […]


ISONIAZID CHEMOPROPHYLAXIS: INDICATIONS AND MANAGEMENT
  by medtextfree
ISONIAZID CHEMOPROPHYLAXIS: INDICATIONS AND MANAGEMENT Efficacy Isoniazid Hepatitis Decision to Use Isoniazid Indications Bibliography Isoniazid (INH) chemoprophylaxis is preventive therapy for a subclinical tuberculous infection to prevent reactivation disease. Although the therapy of active […]



Other reviews about Rifampin, Isoniazid and Pyrazinamide on web:

Learn about the prescription medication Rifater (Rifampin, Isoniazid and Pyrazinamide), drug uses, dosage, side effects, drug interactions, warnings, reviews and patient labeling. Rifater (Rifampin, Isoniazid and Pyrazinamide) Drug Information ...


rifampin, isoniazid, and pyrazinamide patient information. Detailed drug information for the consumer, includes dosage, rifampin, isoniazid, and pyrazinamide side effects and more. rifampin, isoniazid, and pyrazinamide consumer information from ...


Consumer information about the medication RIFAMPIN/ISONIAZID/PYRAZINAMIDE - ORAL (Rifater), includes side effects, drug interactions, recommended dosages, and storage information. RIFAMPIN/ISONIAZID/PYRAZINAMIDE - ORAL (Rifater) side effects ...


Rifampin, Isoniazid, Pyrazinamide, and Ethambutol Drug Information from Drugs.com. Includes Rifampin, Isoniazid, Pyrazinamide, and Ethambutol side effects, interactions and ... Rifampin, Isoniazid, Pyrazinamide, and Ethambutol Drug Information ...


The present review gives a concise summary of the mechanism of action and the molecular basis of resistance to isoniazid, rifampin, and pyrazinamide, the three most important ... Respiratory Research | Full text | The molecular basis of ...


Mayo Clinic offers award-winning medical and health information and tools for healthy living. Rifampin, Isoniazid, and Pyrazinamide (Oral Route) - MayoClinic.com


Rifampin, isoniazid, and pyrazinamide are all antibiotics. This fixed combination of medications belongs to the class of medications called antituberculous antibiotics. This ... Rifater - Uses, Side Effects, Interactions - Drugs - Medbroadcast


Find out all about rifampin isoniazid and pyrazinamide dosage, including the most common uses, side effects, interactions and risk factors from leading medical experts. Rifampin Isoniazid And Pyrazinamide Dosage - a comprehensive view ...


NDA 50-705/S-006 Page 3 RIFATER ® (rifampin, isoniazid and pyrazinamide) Tablets WARNING Severe and sometimes fatal hepatitis associated with isoniazid therapy may occur and may develop ... Rifater (rifampin, isoniazid and pyrazinamide) Tablets


Oral contraceptives (birth control pills) containing estrogen may not work properly if you take them while you are taking rifampin, isoniazid, and pyrazinamide combination. Pyrazinamide - Kosmix : Reference, Videos, Images, News, Shopping ...





Featured Reviews

Reviews Paremyd

Paremyd Drug Description PAREMYD® (hydroxyamphetamine Hydrobromide 1% and tropicamide 0.25%) Convenient One-Drop Solution for Dilation Convenient one-drop formulation is easier to administer than many current regimens consisting...
Read More  |  Review This
Reviews Derma-Smoothe/FS

Derma-Smoothe/FS Drug Description Derma-Smoothe/FS® (fluocinolone acetonide) Topical Oil, 0.01% (Body Oil) For topical use only DRUG DESCRIPTION What are the possible side effects of fluocinolone topical oil (Derma-Smoothe/FS)? Get...
Read More  |  Review This
Reviews Heparin

Heparin Drug Description Heparin Sodium Injection, USP DRUG DESCRIPTION What are the possible side effects of heparin ()? Heparin can cause you to have bleeding episodes while you are using it and for several weeks after you stop....
Read More  |  Review This
Reviews Methylphenidate Extended-Release Tablets

Concerta Drug Description CONCERTA® (methylphenidate HCl) Extended-Release Tablets DRUG DEPENDENCE CONCERTA® should be given cautiously to patients with a history of drug dependence or alcoholism. Chronic abusive use can lead...
Read More  |  Review This
Reviews Fortamet

Fortamet Drug Description FORTAMET® (metformin hydrochloride) Extended-Release Tablets DRUG DESCRIPTION What are the possible side effects of metformin (Fortamet, Glucophage, Glucophage XR, Glumetza, Riomet)? Get emergency...
Read More  |  Review This
Recent News
59sec - the BEST lead management system around!
We tested 59sec - THE lead management system and we love it. 59sec helps small and medium companies to answer leads in maximum 59 seconds. Why...
MOVEorPAY - our favorite facebook app
We do love MOVEorPAY motivational facebook app, because it is very cool and useful. It makes you finish stuff that you know are good for you, but from various reasons, you never do...
ReviewsAZ is almost ready to be officially launched
yes, we have just a few loose ends to tie and we are ready to go :) meanwhile, I am putting some reviews on the site, so people will not get an empty site at the launch....